Visuospatial working memory deficits in remitted patients with bipolar disorder: Susceptibility to the effects of GABAergic agonists

Bipolar Disorders

Volumn 13, Issue 4, 2011, Pages 365-376

  Pan, Yi Ju ^a,b   Hsieh, Ming H ^c   Liu, Shi Kai ^a,c,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Bipolar affective disorder; GABAergic agonist; Visuospatial working memory; Working memory load

Indexed keywords

ALPRAZOLAM; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; DIAZEPAM; ESTAZOLAM; FLUNITRAZEPAM; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; VALPROIC ACID; ZOLPIDEM; ZOPICLONE;

ARTICLE; ATTENTION; BIPOLAR DISORDER; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; DRUG SENSITIVITY; FEMALE; HUMAN; MALE; MENTAL FLEXIBILITY; NEUROLOGIC DISEASE; PARAMETRIC TEST; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SELECTIVE ATTENTION; SUSTAINED ATTENTION; TASK PERFORMANCE; VISUOSPATIAL WORKING MEMORY DEFICIT; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; FEMALE; GABA AGONISTS; HUMANS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 80051623020     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2011.00931.x     Document Type: Article

References (64)

1. Martínez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004; 6: 224-232.
2. Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
3. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93: 105-115.
4. Cavanagh JT, Van Beck M, Muir W, Blackwood DH. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002; 180: 320-326.
5. Torres IJ, Defreitas VG, Defreitas CM et al. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 2010; 71: 1234-1242.
6. Malhi GS, Ivanovski B, Szekeres V, Olley A. Bipolar disorder: it's all in your mind? The neuropsychological profile of a biological disorder. Can J Psychiatry 2004; 49: 813-819.
7. Glahn DC, Almasy L, Barguil M et al. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry 2010; 67: 168-177.
8. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 2006; 8: 103-116.
9. Pavuluri MN, Schenkel LS, Aryal S et al. Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients. Am J Psychiatry 2006; 163: 286-293.
10. Barrett SL, Kelly C, Bell R, King DJ. Gender influences the detection of spatial working memory deficits in bipolar disorder. Bipolar Disord 2008; 10: 647-654.
11. Glahn DC, Bearden CE, Cakir S et al. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord 2006; 8: 117-123.
12. Saperstein AM, Fuller RL, Avila MT et al. Spatial working memory as a cognitive endophenotype of schizophrenia: assessing risk for pathophysiological dysfunction. Schizophr Bull 2006; 32: 498-506.
13. Glahn DC, Therman S, Manninen M et al. Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 2003; 53: 624-626.
14. Sweeney JA, Kmiec JA, Kupfer DJ. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 2000; 48: 674-684.
15. Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001; 158: 1605-1611.
16. McGrath J, Chapple B, Wright M. Working memory in schizophrenia and mania: correlation with symptoms during the acute and subacute phases. Acta Psychiatr Scand 2001; 103: 181-188.
17. Pirkola T, Tuulio-Henriksson A, Glahn D et al. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol Psychiatry 2005; 58: 930-936.
18. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999; 175: 246-251.
19. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008; 38: 771-785.
20. Silk TJ, Bellgrove MA, Wrafter P, Mattingley JB, Cunnington R. Spatial working memory and spatial attention rely on common neural processes in the intraparietal sulcus. Neuroimage 2010; 53: 718-724.
21. Mayer JS, Bittner RA, Nikolic D, Bledowski C, Goebel R, Linden DE. Common neural substrates for visual working memory and attention. Neuroimage 2007; 36: 441-453.
22. Sreenivasan KK, Jha AP. Selective attention supports working memory maintenance by modulating perceptual processing of distractors. J Cogn Neurosci 2007; 19: 32-41.
23. Menzies L, Ooi C, Kamath S et al. Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. Arch Gen Psychiatry 2007; 64: 156-167.
24. Krieger S, Lis S, Janik H, Cetin T, Gallhofer B, Meyer-Lindenberg A. Executive function and cognitive subprocesses in first-episode, drug-naive schizophrenia: an analysis of N-back performance. Am J Psychiatry 2005; 162: 1206-1208.
25. Frangou S, Kington J, Raymont V, Shergill SS. Examining ventral and dorsal prefrontal function in bipolar disorder: a functional magnetic resonance imaging study. Eur Psychiatry 2008; 23: 300-308.
26. Vinogradov S, Fisher M, Warm H, Holland C, Kirshner MA, Pollock BG. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am J Psychiatry 2009; 166: 1055-1062.
27. Henin A, Mick E, Biederman J et al. Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? J Clin Psychiatry 2009; 70: 1178-1185.
28. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003; 64: 86-93.
29. Reilly JL, Harris MS, Khine TT, Keshavan MS, Sweeney JA. Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry 2007; 62: 818-821.
30. Minzenberg MJ, Poole JH, Benton C, Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry 2004; 161: 116-124.
31. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009; 70: 1588-1597.
32. Goldberg JF, Burdick KE. Cognitive side effects of anticonvulsants. J Clin Psychiatry 2001; 62 (Suppl. 14): 27-33.
33. Curran HV. Benzodiazepines, memory and mood: a review. Psychopharmacology 1991; 105: 1-8.
34. Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005; 66 (Suppl. 2): 9-13.
35. Michael GA, Bacon E, Offerlin-Meyer I. Lorazepam induces multiple disturbances in selective attention: attentional overload, decrement in target processing efficiency, and shifts in perceptual discrimination and response bias. J Psychopharmacol 2007; 21: 691-699.
36. Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005; 35: 307-315.
37. McGurk SR, Lee MA, Jayathilake K, Meltzer HY. Cognitive effects of olanzapine treatment in schizophrenia. Med Gen Med 2004; 6: 27.
38. McGurk SR, Green MF, Wirshing WC et al. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophrenia Res 2004; 68: 225-233.
39. Young RC, Biggs JT, Ziegler E, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978; 133: 429-435.
40. Hamilton M. A rating scale for depression. J Neural Neurosurg Psychiatry 1960; 23: 56-62.
41. Chang CJ, Chen WJ, Liu SK et al. Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan. Schizophr Bull 2002; 28: 379-392.
42. Nurnberger JI Jr, Blehar MC, Kaufmann CA et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51: 849-859.
43. Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology. Rockville: National Institute of Mental Health, 1976.
44. Weschler D. Wais-III Administration and Scoring Manual. San Antonio: The Psychological Corporation, 1997.
45. Awh E, Vogel EK, Oh SH. Interactions between attention and working memory. Neuroscience 2006; 139: 201-208.
46. Liu SK, Hsieh MH, Chen WJ. Facial affect recognition in patients with bipolar disorder and schizophrenia across the acute phase. Proceedings of the 40th Anniversary Meeting of the Taiwanese Society of Psychiatry, Taipei, Taiwan, R.O.C., 2001: 16-17.
47. Asarnow RF, Granholm E, Sherman T. Span of apprehension in schizophrenia. In: Steinhauer SR, Gruzelier JH, Zubin J eds. Neuropsychology, Psychophysiology, and Information Processing. Handbook of Schizophrenia, Volume 5. New York: Elsevier, 1991: 335-370.
48. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tuscon: Neuropsychological Press, 1985.
49. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry 2010; 167: 686-693.
50. Adler CM, Holland SK, Schmithorst V, Tuchfarber MJ, Strakowski SM. Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disord 2004; 6: 540-549.
51. Gooding DC, Tallent KA. The association between antisaccade task and working memory task performance in schizophrenia and bipolar disorder. J Nerv Ment Dis 2001; 189: 8-16.
52. Brown GG, Lohr J, Notestine R, Turner T, Gamst A, Eyler LT. Performance of schizophrenia and bipolar patients on verbal and figural working memory tasks. J Abnorm Psychol 2007; 116: 741-753.
53. Badcock JC, Michiel PT, Rock D. Spatial working memory and planning ability: contrasts between schizophrenia and bipolar I disorder. Cortex 2005; 41: 753-763.
54. Baddeley A. The episodic buffer: a new component of working memory? Trends Cogn Sci 2000; 4: 417-423.
55. Fukuda K, Awh E, Vogel EK. Discrete capacity limits in visual working memory. Curr Opin Neurobiol 2010; 20: 177-182.
56. Bays PM, Husain M. Dynamic shifts of limited working memory resources in human vision. Science 2008; 321: 851-854.
57. Drapier D, Surguladze S, Marshall N et al. Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task. Biol Psychiatry 2008; 64: 513-520.
58. Mur M, Portella MJ, Martínez-Arán A, Pifarre J, Vieta E. Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients. Psychopathology 2009; 42: 148-156.
59. Gilbert AM, Olino TM, Houck P, Fagiolini A, Kupfer DJ, Frank E. Self-reported cognitive problems predict employment trajectory in patients with bipolar I disorder. J Affect Disord 2010; 124: 324-328.
60. Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J et al. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J Affect Disord 2008; 109: 286-299.
61. Hashimoto T, Arion D, Unger T et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2008; 13: 147-161.
62. Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology 2004; 174: 143-150.
63. Lewis DA, Cho RY, Carter CS et al. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry 2008; 165: 1585-1593.
64. Craddock N, Jones L, Jones IR et al. Strong genetic evidence for a selective influence of GABA(A) receptors on a component of the bipolar disorder phenotype. Mol Psychiatry 2010; 15: 146-153.